Commonwealth Hematology Oncology PC-Concord is a clinical research site located in Concord, Massachusetts, United States 01742.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
Commonwealth Hematology Oncology PC-Concord has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7.
Sponsors: National Cancer Institute (NCI).
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Commonwealth Hematology Oncology PC-Concord has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Commonwealth Hematology Oncology PC-Concord has 4 clinical trials on record, with 3 currently active. Their work covers Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7.
Commonwealth Hematology Oncology PC-Concord has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.